Egyptian International Pharmaceutical Industries Co.EGX: PHAR

EIPICO Says EIPICO 3 Facility Gets Final Operating License From Egyptian Drug Authority

· Issued by Egyptian International Pharmaceutical Industries Co.

EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY EGX:PHAR:

  • EIPICO 3 FACILITY GETS EGYPTIAN DRUG AUTHORITY (EDA) APPROVAL AND INTRODUCES ITS FIRST BIOLOGICAL PRODUCT "ADALIMAB"

  • EDA APPROVAL PREPARES GROUND FOR STARTING OPERATIONS IN Q1 OF 2026

  • RECEIVES FORMAL REQUEST AND PURCHASE ORDER TO SUPPLY ADALIMAB TO NAMIBIA

Egyptian International Pharmaceutical Industries Co. on 6ix

Earlier from Egyptian International Pharmaceutical Industries

Later from Egyptian International Pharmaceutical Industries

All Egyptian International Pharmaceutical Industries news releases